Furukawa Y - Search Results

1

Homopiperazine derivatives as a novel class of proteasome inhibitors with a unique mode of proteasome binding.

Kikuchi J, Shibayama N, Yamada S, Wada T, Nobuyoshi M, Izumi T, Akutsu M, Kano Y, Sugiyama K, Ohki M, Park SY, Furukawa Y. Kikuchi J, et al. Among authors: furukawa y. PLoS One. 2013 Apr 11;8(4):e60649. doi: 10.1371/journal.pone.0060649. Print 2013. PLoS One. 2013. PMID: 23593271 Free PMC article.

2

Apaf-1 is a mediator of E2F-1-induced apoptosis.

Furukawa Y, Nishimura N, Furukawa Y, Satoh M, Endo H, Iwase S, Yamada H, Matsuda M, Kano Y, Nakamura M. Furukawa Y, et al. J Biol Chem. 2002 Oct 18;277(42):39760-8. doi: 10.1074/jbc.M200805200. Epub 2002 Jul 30. J Biol Chem. 2002. PMID: 12149244 Free article.

3

Identification of novel p53-binding proteins by biomolecular interaction analysis combined with tandem mass spectrometry.

Kikuchi J, Furukawa Y, Hayashi N. Kikuchi J, et al. Among authors: furukawa y. Mol Biotechnol. 2003 Mar;23(3):203-12. doi: 10.1385/MB:23:3:203. Mol Biotechnol. 2003. PMID: 12665691

4

Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4c.

Nishimura N, Furukawa Y, Sutheesophon K, Nakamura M, Kishi K, Okuda K, Sato Y, Kano Y. Nishimura N, et al. Among authors: furukawa y. Oncogene. 2003 Jun 26;22(26):4074-82. doi: 10.1038/sj.onc.1206498. Oncogene. 2003. PMID: 12821941

5

Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it.

Kawano T, Horiguchi-Yamada J, Iwase S, Furukawa Y, Kano Y, Yamada H. Kawano T, et al. Among authors: furukawa y. Mol Cell Biochem. 2004 Mar;258(1-2):25-33. doi: 10.1023/b:mcbi.0000012830.96393.b9. Mol Cell Biochem. 2004. PMID: 15030167

6

Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.

Kawano T, Horiguchi-Yamada J, Saito S, Iwase S, Furukawa Y, Kano Y, Yamada H. Kawano T, et al. Among authors: furukawa y. Leuk Res. 2004 Jun;28(6):623-9. doi: 10.1016/j.leukres.2003.10.022. Leuk Res. 2004. PMID: 15120940

7

Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro.

Kano Y, Akutsu M, Tsunoda S, Izumi T, Mori K, Fujii H, Yazawa Y, Mano H, Furukawa Y. Kano Y, et al. Among authors: furukawa y. Cancer Chemother Pharmacol. 2004 Dec;54(6):505-13. doi: 10.1007/s00280-004-0839-5. Epub 2004 Aug 31. Cancer Chemother Pharmacol. 2004. PMID: 15340759

8

Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228).

Sutheesophon K, Nishimura N, Kobayashi Y, Furukawa Y, Kawano M, Itoh K, Kano Y, Ishii H, Furukawa Y. Sutheesophon K, et al. Among authors: furukawa y. J Cell Physiol. 2005 May;203(2):387-97. doi: 10.1002/jcp.20235. J Cell Physiol. 2005. PMID: 15515013

9

Methylation silencing of the Apaf-1 gene in acute leukemia.

Furukawa Y, Sutheesophon K, Wada T, Nishimura M, Saito Y, Ishii H, Furukawa Y. Furukawa Y, et al. Mol Cancer Res. 2005 Jun;3(6):325-34. doi: 10.1158/1541-7786.MCR-04-0105. Mol Cancer Res. 2005. PMID: 15972851

10

Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.

Sutheesophon K, Kobayashi Y, Takatoku MA, Ozawa K, Kano Y, Ishii H, Furukawa Y. Sutheesophon K, et al. Among authors: furukawa y. Acta Haematol. 2006;115(1-2):78-90. doi: 10.1159/000089471. Acta Haematol. 2006. PMID: 16424655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,383 results

Search Page

Filters